BLSC..... A Look At The Numbers...
This doesn't reflect their new contract with Premier that
exposes their products to 1800 hospitals and other medical providers...
.........................
BIO-LOGIC SYSTEMS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Periods Ended August 31, 1997 and 1996
Three Months Ended Six Months Ended
August 3l, August 31,
1997 1996 1997 1996
NET SALES $ 4,346,349 $ 3,574,920 $ 8,755,030 $ 6,419,646
COST OF SALES 1,404,592 1,185,065 2,867,522 2,245,711
Gross profit 2,941,757 2,389,855 5,887,508 4,173,935
OPERATING EXPENSES:
Selling, general,
and administrative 2,047,330 1,563,070 4,126,570 3,402,383
Research and
development 629,122 465,876 1,201,085 833,343
Total operating
expenses 2,676,432 2,028,946 5,327,655 4,235,726
OPERATING INCOME
(LOSS) 265,305 360,909 559,853 (61,791)
OTHER INCOME (EXPENSE):
Interest income 51,643 54,301 100,287 114,879
Interest expense (9,440) (14,857) (21,605) (28,011)
Miscellaneous (15) 50 787 744
TOTAL OTHER INCOME 42,188 39,494 79,469 87,612
INCOME BEFORE INCOME
TAXES 307,493 400,403 639,322 25,821
PROVISION FOR INCOME
TAXES 99,013 117,400 205,863 24,458
NET INCOME $ 208,480 $ 283,003 $ 433,459 $ 1,363
NET INCOME PER SHARE $ 0.05 $ 0.07 $ 0.11 $ 0.00
Weighted Average
Shares Outstanding 4,169,598 4,212,628 4,114,164 4,270,602
Jim |
